Skip to main content
رجوع
MLTX logo

MoonLake Immunotherapeutics

جودة البيانات: 100%
MLTX
NASDAQ Healthcare Biotechnology
KWD 16.87
▲ KWD 0.60 (3.69%)
القيمة السوقية: 1.21B
نطاق اليوم
KWD 16.50 KWD 17.32
نطاق 52 أسبوعًا
KWD 5.95 KWD 62.75
حجم التداول
774,940
متوسط 50 يوم / 200 يوم
KWD 16.85 / KWD 29.02
الإغلاق السابق
KWD 16.27

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -5.3 0.4
P/B 4.0 2.9
ROE % -60.5 3.8
Net Margin % 3.9
Rev Growth 5Y % 10.0
D/E 0.3 0.2

النقاط الرئيسية

Debt/Equity of 0.25 — conservative balance sheet
Negative free cash flow of -196.04M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-60.51%
ROIC-48.30%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.25
Current Ratio9.27
Interest Coverage-33.78

التقييم

P/E Ratio
-5.32
P/B Ratio3.97
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -227.32M
ROE -60.51% ROA -53.56%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -196.04M
ROIC -48.30% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.25 Current Ratio 9.27
Interest Coverage -33.78 Dividend Yield 0.00%
Valuation
P/E Ratio -5.32 P/B Ratio 3.97
P/S Ratio N/A PEG Ratio -0.04
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 1.21B Enterprise Value 951.24M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 0.0 0.0 0.0
Net Income -227.32M -118.94M -36.01M -49.97M -53.64M
EPS (Diluted) -3.53 -1.89 -0.73 -2.20 -1.45
Gross Profit -2.62M 0.0 0.0 0.0 -4,971.0
Operating Income -244.83M -143.09M -54.12M -65.06M -53.58M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 424.43M 477.93M 526.54M 76.84M 9.68M
Total Liabilities 119.95M 24.54M 13.05M 8.08M 21.33M
Shareholders' Equity 304.48M 446.83M 495.68M 48.90M -11.65M
Total Debt 75.71M 2.83M 3.70M 282,580.0 15.00M
Cash & Equivalents 334.52M 180.43M 451.17M 39.51M 8.04M
Current Assets 421.69M 474.29M 514.17M 76.51M 9.64M
Current Liabilities 45.48M 22.46M 9.97M 7.67M 21.09M